Myung In Pharmaceutical Company   Report issue

For profit Phase 4
Founded: Seoul Korea, Republic of (1985)
Status: No NME R&D (1985)

Organization Overview

First Clinical Trial
2010
NCT01174693
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

clopidogrel (plavix) (1 trial)

triflusal (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cerebral Infarction (Phase 4)

Infarction (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2